reserved.
lated that serum G-CSF concentrations might be less elevated in neutropenic neonates than in neutropenic adults. Indeed, serum concentrations were relatively low in all nonneutropenic subjects; 92 f 34 pg/mL (mean f SEM) in 10 preterm neonates, 1 14 f 21 pg/mL in 16 term neonates, and 45 f 1 3 pg/mL in 11 healthy adults. Serum concentrations were not elevated in 7 neutropenic neonates (39 f 17 pg/mL) but were in 8 neutropenic adults (2101 f 942 pg/mL, P < .05 Y healthy adults). Other studies suggested that the lower G-CSF production in neonates is not counterbalanced by a heightened sensitivity of G-CSF-responsive progenitors to G-CSF. Therefore, we speculate that newborn infants, particularly those delivered prematurely, generate comparatively low quantities of G-CSF after inflammatory stimulation, and that this might constitute part of the explanation for their defective upregulation of neutrophil production and function during infection.
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paring the sensitivity of granulocytic progenitors obtained from adults, term neonates, and preterm neonates with recombinant G-CSF.
MATERIALS AND METHODS

Subjects.
For the studies of G-CSF production by isolated monocytes, umbilical cord blood was obtained by needle puncture of an umbilical vessel at its attachment to the placenta immediately after delivery of preterm (23 to 34 weeks of gestation) and term (38 to 4 1 weeks of gestation) neonates, and blood was obtained by venipuncture of healthy adults. For serum G-CSF concentrations, venous blood was obtained from l l healthy adults, from 8 noninfected adults with chemotherapy-associated neutropenia, from I6 healthy term neonates (38 to 41 weeks ofgestation), from 10 noninfected preterm neonates (29 to 35 weeks of gestation), and from 7 noninfected neonates with neutropenia. For studies of the sensitivity of granulocytic progenitors to recombinant G-CSF, bone marrow (BM) cells were aspirated from 2 healthy adult volunteers, and umbilical cord blood was obtained from 2 term and 2 preterm neonates. The studies were performed in accordance with protocols approved by the University of Utah Institutional Review Board (Salt Lake City, UT), and informed consent was obtained from participants.
Monocyte preparation. Monocyte-enriched cell populations were prepared by incubating light-density blood cells, obtained by density gradient centrifugation over Ficoll-Hypaque (specific gravity < 1.077), with murine antibodies directed against human T lymphocytes (antihuman leu-1 and antihuman leu-5b), B lymphocytes (antihuman leu-12), progenitor cells (anti-HPCA-1; all from Becton Dickinson, San Jose, CA), and erythrocytes (antiglycopborin antibodies; kindly supplied by Dr Richard Langlois, Lawrence Livermore Laboratories. Livermore, CA). Antibodybound cells were extracted from the remaining mononuclear cells using magnetic beads coated with goat antimurine antibodies (Dynal Inc, Great Neck, NY). The monocyte concentrations in the resultant cell populations were determined by a naphthyl esterase staining (Sigma, St Louis, MO MN, 0 to 100 ng/mL), based on concentrations used for maximal G-CSF production by other investigators?l0." or with LPS (Escerichia coli Serotype 0128:B12,0 to IO pg/mL; Sigma). Other studies were performed by incubating monocytes with IL-1 a ( 10 ng/mL) or LPS (10 ng/mL) alone or in combination with Actinomycin D (1 pg/mL; Sigma). The purified recombinant IL-la had a specific activity of 2 5 X 10' U/mg and a purity of 295% by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Quantification of G-CSF. G-CSF concentrations were measured by enzyme-linked immunosorbant assay (ELISA; R & D Systems). The minimal G-CSF concentration detectable was I 1 pg/ mL. The ELISA recognized both natural and recombinant G-CSF and showed no cross-reactivity with the following cytokines: IL-I a, IL-lj3, IL-2, IL-3, IL-4, IL-6, tumor necrosis factor a (TNFa), TNFP, granulocyte-macrophage-CSF (GM-CSF), transforming growth factor TGFj3 I (TGFP I), TGFj32, and platelet-derived growth factor.
RNA isolation and Northern blot analysis. RNA was prepared from mononuclear cells of 6 adults, 6 term neonates, and 6 preterm neonates (gestational age, 27 to 34 weeks) before and after 24 hours of culture in the presence or absence of I L 1 a. Similarly, RNA was prepared from monocytes of 2 adults, 2 term neonates, and 2 preterm neonates after stimulation with LPS for 12 hours, for comparison of G-CSF transcript content using competitive polymerase chain reaction (PCR). A guanidinium extraction buffer was added to the cells, and RNA was isolated by using the method described by Chomczynski and Sacchi." The RNA was subjected to electrophoresis through a 1% agarose-formaldehyde gel, transferred to a biotrace nylon membrane (Gelman Sciences, Ann Arbor, MI), and immobilized by UV cro~s-1inking.l~~'~ The human G-CSF probe (kindly supplied by Dr Steve Gillis, Immunex Corp, Seattle, WA) was labeled, hybridized to the blot, washed, and subjected to autoradiography.
Reverse transcriptase reaction. First-strand cDNA, required for the subsequent competitive PCR, was prepared from RNA using a modification ofthe procedure of Sambrook et al.I3 Briefly, 0.1 pg of total cellular RNA was incubated with 200 U of Moloney murine leukemia virus reverse transcriptase (GIBCO-BRL, Gaithersburg, MD) for 1 hour at 37°C. Reaction components included 50 mmol/ L KCl, 10 mmol/L Tris-CI, pH 8.3, 4.0 mmol/L MgCl,, 0.01% gelatin, 1 mmol/L dithiothreitol, 100 pmol of random hexamers (Boehringer, Mannheim, Germany), 500 pmol/L dNTPs (Perkin Elmer-Cetus, Norwalk, CT), and 40 U of RNAasin placental ribonuclease inhibitor (Promega, Madison, WI) in a final reaction volume of 20 pL. The reverse transcriptase was heat-inactivated at 95°C for 5 minutes after the reaction.
Competitive template preparation. A 285-bp fragment of the human G-CSF gene between positions 1,123 and 1,407 of HUMGCSFI5 was amplified, using PCR, from high molecular weight DNA isolated from L2379 K1462, a lymphoblastoid cell line. This fragment includes 107 bp of exon 3, all of intervening sequence 3, and the first 34 bp of exon 4. The upstream primer was 5'-GTG CCA CCT ACA AGC TGT GC-3', and the downstream primer was 5'-AAA GGC CGC TAT GGA GTT GG-3'. These same primers amplify a 141-bp fragment from the reverse transcribed G-CSF mRNA.
Competitive PCR. The competitive PCR techniques used in this study are modifications of methods previously described.l6-" Briefly, 0.1 pg of the competitive template DNA in 10 pL of water was added to each 0.65-mL microcentrifuge tube. Samples were overlayed with mineral oil, heat-denatured for 10 minutes at 94"C, and then quenched on ice. A master mix was prepared on ice so that the final concentration of reagents added to each sample was 2.5 U of Amplitaq DNA polymerase (Perkin Elmer-Cetus), 200 pmol/L dNTPs (Perkin Elmer-Cetus), 1.25% formamide,lg 50 mmol/L KCl, 10 mmol/L Tris-CI (pH 8.3 at 22"C), 1.5 mmol/L MgCl,, 0.01% gelatin, and 100 pmol of each upstream and downstream primer. Water was added to bring the volume to 35 pL. A 5-pL aliquot of each 20-pL reverse transcriptase reaction was added to the tubes, bringing the final volume of each tube to 50 pL. The samples were kept on ice until the block of the Perkin Elmer thermocycler was 9 4 T , whereupon the samples were immediately placed into the block. Samples were amplified for 30 cycles of 1 minute at 94°C followed by 1 minute of annealing at 6 2 T , which was followed by 2 minutes of extension at 72°C. On completion of the final cycle, samples were incubated for 5 minutes at 72°C.
Analysis anddensitometry. Electrophoresis was performed on a 30-pL aliquot of each sample through a 2.5% Nuseive/l% Seakem (FMC Corp, Rockland, ME) agarose gel in 1 X Tris-acetate running buffer for 3 hours at 2 VDC/cm constant current. Gel and running buffer each contained 0.5 pg of ethidium bromide per 1 mL. The gels were illuminated with UV 280-nm light and photographed with type 55 positive/negative Polaroid film (Polaroid Corp, Cambridge, MA) through a no. 15 wratten and 2E UV filter. The negative was scanned transmissively, and integrated intensities of the bands were determined with the Bio Image Visage 60 system (Millipore Corp, Bedford, MA), which uses a high-speed two-dimensional array camera providing 5 12 by 5 12 pixel resolution.
Direct high-pevformance liquid chromatography (HPLC) of PCR products. To confirm the densitometric analysis, a IO-pL aliquot of each PCR sample was chromatographed through a Gen-Pak FAX (4.6 mm X 100 mm) anion exchange column (Millipore Corp, Waters Chromatography Division) at 0.75 mL/min using a linear gradient from 25% to 75% Bin 30 minutes maintained at 30°C (A: 25 mmol/L Tris-HCL, 1 mmol/L EDTA, pH 8.0; B: buffer A + 1.0 mol/L NaCl). After each separation, the column was regenerated with 3.0 mL of 0.1 N phosphoric acid followed by reequilibration of the column to initial conditions with 15-column volumes of buffer at 40% B and 60% A. UV absorbance at 260 nm was measured with a Waters model 486 Tunable Absorbance Detector.
Response of granulocytic progenitors to recombinant G-CSF. Light-density cells were incubated for 90 minutes in plastic flasks at 37"C, after which nonadherent cells were incubated with murine antihuman monocyte, anti-T lymphocyte, and antiglycophorin antibodies as described above. Cells to which IgG had attached were removed by incubating in plates coated with goat antimouse IgG (Zymed, San Francisco, CA), after which nonadherent cells were cultured in quadruplicate at a density of 2 to 10 X IO3 cells/mL in 1-mL dishes containing a minimal essential media (aMEM), 5 X mol/L 8-mercaptoethanol (Eastman Chemical Co, Rochester, NY), 30% fetal calf serum (Hyclone), 1% bovine albumin (Sigma), and 1.1% methylcellulose (Sigma). Cells were cultured in the presence of various concentrations (0 to IO ng/mL) of G-CSF (R & D Systems). All plates received anti-GM-CSF antibody (30 pg/mL). Antihuman GM-CSF antibodies were raised in goats immunized with purified recombinant human GM-CSF (R & D Systems). At a concentration of 10 pg/mL, anti-GM-CSF neutralized greater than 90% of the biologic activity of 0.5 ng/mL of recombinant human GM-CSF. No cross-reactivity with IL-I, IL-2, IL-3, IL4, IL-6, TNF, or G-CSF was detected by Western blot or ELISA. After 14 days, colonies were categorized in situ as colony forming unit-GM (CFU-GM) colonies if composed of greater than 50 cells.
The Student's t-test with the Bonfaroni correction for multiple observations was used to assess differences in G-CSF production by monocytes. Differences in G-CSF serum concentrations between neonates and adults were assessed using the Student's t-test. Differences in G-CSF serum concentrations between healthy and neutropenic subjects were assessed using the Statistical analysis. 
RESULTS
Accirmirlarion of G-CSF in sirpernatanrs of monoc.vre.% The plated adult cells consisted of 9 I% f 3% monocytes (mean f SD). The percentage of monocytes in plated cells from term infants was 9370 f 4%. and from preterm infants was 83% f 1 170. Concentrations of G-CSF in supernatants of plated cells, 24 hours after stimulation with various concentrations of IL-la, are shown in Fig 1. The maximal G-CSF concentration in supernatants of adult cells was 8,699 f 5,529 pg/mL/106 monocytes (mean f SEM). This was significantly greater than the maximal concentration in supernatantsofterm (2,557 f 442 pg/mL, P e .05) and of preterm (879 f 348 pg/mL. P < .05) cells. The magnitude of G-CSF accumulation by preterm neonatal monocytes in response to IL-1 was not significantly increased compared with baseline values.
The kinetics of G-CSF production by monocytes stimulated with IL-l a is shown in Fig 2. G-CSF was detectable in low concentrations ( 4 0 pg/mL/106 monocytes) after 2 hours of incubation. Plateau G-CSF accumulation was attained in all groups by 24 hours. Once again, peak G-CSF accumulation in supernatants from adult monocytes (5,562 f 2.5 12 pg/106 monocytes) was greater than that from term (1,632 f 261 pg) and from preterm (491 f 224 pg) monocytes. After stimulation with LPS, G-CSF accumulation in supernatants from monocytes of preterm infants was not significantly increased from baseline values and was less than that from supernatants of cells of adults and term neonates (Fig 3) . Incubation of IL-I-stimulated monocytes with actinomycin D resulted in abrogation of G-CSF (57 f 19 pg/mL v 5,853 f 720 pg/mL in the controls: P < .05).
Two varieties of studies were performed. Because of the relatively small numbers of purified monocytes obtained from blood of infants, initial studies of G-CSF mRNA content were performed using Northern blot analysis of lightdensity mononuclear cells. rather than purified monocytes. SubseCellular accirmirlarion q1'G-C.W mRNA. quently, G-CSF mRNA content was assessed on purified monocytes using competitive PCR. As shown in Fig 4, be- fore incubation of light-density mononuclear cells with IL-I , no G-CSF mRNA was detected. After incubation of mononuclear cells in the absence of IL-la, G-CSF transcripts were detected in cells of 2 adult subjects and 1 preterm subject. The ratio ofthe optical density ofG-CSF transcripts to 28-S ribosomal RNA fragments was 8.7 f 1. 1 through 6) . 6 term infants (lanes 7 through 12). and 6 pretenn infants (lanes 13 through 18) before stimulation with IL- la (lanes 1,7, and 13) . in the absence of stimulation (lanes 2,3, 8,9,14, and 15) and after stimulation with IL-1 a for 2 4 hours (adults, lanes 4 through 6; term neonates, lanes 10 through 12; and preterm infants, lanes 16 to 18). The 2 8 4 ribosomal subunit band (lower panel) is illustrated to compare RNA loading efficiency in each lane.
cDNA product, corresponding to the G-CSF mRNA content within the cultured monocytes, appears as a 141-bp band, whereas the amplified G-CSF genomic product appears as a 285-bp band. G-CSF transcript content was less in preterm monocytes than in term or adult monocytes. using both densitometric and HPLC analysis. P < .OS (Table I) .
Serum G-CSF concentrations from healthy preterm and term neonates were higher than those from adults ( Table 2 ). Four neonates with neutropenia due to maternal hypertension.'" and 3 with unexplained neutropenia had serum G-CSF concentrations that were not different from those of nonneutropenic neonates. In contrast, 8 adults with neutropenia associated with chemotherapy had serum G-CSF concentrations that were higher than those for nonneutropenic adults. There was no evidence of infection in any of the 7 neutropenic neonates nor in the 8 neutropenic adults.
Re.yponse qf graniclocvte progenitors to recombinant G-CSF. The sensitivity ofgranulocytic progenitors from preterm and term infants to recombinant G-CSF was not different from that of progenitors from adults (Fig 6) .
Serum concentrations (?fG-CSF.
DISCUSSION
Newborn infants, particularly those delivered prematurely, have quantitative and qualitative neutrophil deficien~ies.~~~~'' From animal studies, it has been found that the quantitative neutrophil deficiencies include a small reserve of neutrophil progenitors,2' a small reserve of stored mature neutrophil^.^' a delay in upregulation of neutrophil production after bacterial challenge." and a limited capacity to accelerate cycling of CFU-GM after bacterial chalIer~ge.~'.~~ The qualitative developmental neutrophil deficiencies include decreased adherence?' C3bi expression,28 def~rmability.~~ chem~taxis,~".~' phagocyto~is,~~ and oxidative metaboli~m.~"'"~
The physiologic role of G-CSF appears to involve acceleration of neutrophil production and upregulation of certain neutrophil functions."' For that reason. defective production of G-CSF or defective interaction of cells with G-CSF might underlie several of the neonate's neutrophil defects. Defective interaction of progenitors with G-CSF seems unlikely in view ofour present studies showing normal in vitro responsiveness ofgranulocytic progenitors from neonates to recombinant G-CSF. In contrast, the hypothesis of defective G-CSF production is supported by the present studies. Specifically. low concentrations of G-CSF protein were observed in supernatants of cultured monocytes from preterm neonates, after stimulation with IL-In or LPS. Additionally. G-CSF mRNA content of monocytes from preterm neonates was less than that in monocytes from adults.
The accumulation of G-CSF protein in the supernatants and G-CSF transcript content of term neonatal monocytes was significantly less than that observed in adult monocytes after stimulation with IL-In. These results are consistent with reports by Cairo et describing diminished production of G-CSF protein and mRNA by mononuclear cells from term cord blood stimulated with phorbol myristate acetate and phytohemagglutinin. When stimulated with LPS, accumulation of G-CSF protein and m R N A by term neonatal monocytes and adult monocytes was not significantly different. The discrepancy between the response to these inflammatory mediators underscores the fact that they act through different mechanisms. IL-1 acts through specific IL-1 receptors that bind and are subsequently internalized, initiating signal transduction, transcription, and t r a n~l a t i o n .~~'~~ The effects of LPS appear to be more pleiotropic. Although its effects on the monocyte membrane are not well defined, it appears to initiate at least two distinct signal transduction cascades, one mediated by rapid events such as increase of intracellular calcium and phosphorylation of several proteins through protein kinase C and another mediated by synthesis of gene regulatory proteins.39 Each avenue of signal transduction might initiate a different set of effector functions. Alternatively, the capacity of monocytes to respond to different inflammatory signals might mature at different times in monocytic differentiation. For instance, the capacity of macrophages to synthesize and process IL-1 has previously been shown to be dependent on the degree of differentiati~n.~" Thus, the monocytes present in the blood of earlier gestation infants might not respond to LPS or to IL-I, but monocytes from the blood of term infants might be sufficiently differentiated to respond to LPS but not to IL-1. Based on these findings, we suspected that serum concentrations of G-CSF in neutropenic neonates might not become as elevated as would those of neutropenic adults. Indeed, we observed relatively low concentrations of G-CSF in the serum of healthy neonates and adults and found no increase from these levels in 7 neutropenic neonates. To the contrary, G-CSF concentrations in the sera of adults undergoing chemotherapy were high during periods of neutropenia. G-CSF levels in our group of neutropenic adults were similar to those reported by other inve~tigators.~' Our finding of relatively low concentrations of G-CSF in umbilical cord blood agrees with the studies of Cairo et a136 and Rodwell et al. 42 In contrast, Laver et a143 reported high levels of G-CSF biologic activity in umbilical cord blood compared with adult blood. Although our studies, like those of Laver et al, 43 showed higher concentrations of G-CSF in cord blood than in adult blood, we interpret both as being low compared with the 10-to 500-fold increases in G-CSF blood levels found during myeloid regeneration in adults.
In mice,44 rat^,^^,'^ and nonhuman primate^,^ G-CSF administration increases resistance to otherwise lethal inocula of bacteria. Similarly, G-CSF administration to humans increases neutrophil production and upregulates neutrophil adhesiveness, phagocytic activity, superoxide generation, and antibody-dependent cellular t o x i~i t y .~~-~' In light of those findings plus our present observations of diminished G-CSF generation by neonates, perhaps G-CSF administration might deserve experimental consideration as an adjunct to preventing or treating infections in preterm neonates.
